AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 190 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $88,000 | +51.7% | 7,584 | +29.9% | 0.00% | +50.0% |
| Q2 2019 | $58,000 | +1.8% | 5,840 | +32.2% | 0.00% | 0.0% |
| Q1 2019 | $57,000 | -14.9% | 4,416 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $67,000 | -23.9% | 4,416 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $88,000 | +2.3% | 4,416 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $86,000 | -3.4% | 4,416 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $89,000 | +74.5% | 4,416 | +15.0% | 0.00% | +50.0% |
| Q4 2017 | $51,000 | -7.3% | 3,840 | +29.0% | 0.00% | 0.0% |
| Q3 2017 | $55,000 | +37.5% | 2,976 | +37.8% | 0.00% | +100.0% |
| Q2 2017 | $40,000 | +66.7% | 2,160 | +107.7% | 0.00% | 0.0% |
| Q1 2017 | $24,000 | -31.4% | 1,040 | +4.8% | 0.00% | 0.0% |
| Q4 2016 | $35,000 | – | 992 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |